Furthermore, the analysis of clinical specimens from bladder TCC patients showed that 53 (43%) had positive miR-424 immunoreactivity in bladder cancer tissues and there was a negative correlation between the expression levels of miR-424 and DNMT1. Here, DNMT1 is linked to urinary bladder cancer.